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doi:10.1016/j.jtcvs.2007.10.01146 The Journal of Thoracic and CardObjective: We assessed predictors and temporal characteristics of cardiac risk in pa-
tients undergoing stress single-photon emission computed tomography after coronary
artery bypass grafting.
Methods: Stress cardiac tomography was performed in 362 patients 5 years after cor-
onary artery bypass grafting. Cardiac death and myocardial infarction were consid-
ered as events. Cox proportional hazards analysis was used to identify predictors of
events and parametric survival analysis to predict time to events.
Results: During a median follow-up of 27 months, 22 cardiac events occurred (6.1%
cumulative event rate). At multivariable Cox analysis, ischemia at cardiac tomogra-
phy (hazards ratio 3.7, 95% confidence interval 1.5–9.1; P5 .004), and diabetes (haz-
ards ratio 3.6, 95% confidence interval 1.5–8.5; P 5 .006) resulted in independent
predictors of events. Event-free survival was 96% in patients with normal cardiac
tomography, 86% in those with abnormal tomography without ischemia, and 70%
in those with (log–rank 10.6, P for trend 5 .008). The parametric survival model
revealed that the cardiac risk was greater for all time intervals and accelerated more
over time in patients with ischemia than in those without (c2 21.4, P , .0001).
Patients without diabetes and normal cardiac tomography remained below a defined
risk level (5%) for the entire follow-up period.
Conclusion: Stress cardiac tomography performed 5 years after coronary artery
bypass grafting is useful to characterize the risk of cardiac events and its temporal
variation. Parametric survival model estimates the predicted time to risk and the level
of risk at specific time intervals after coronary artery bypass grafting.
M
yocardial perfusion imaging with single-photon emission computed to-
mography (SPECT) has been demonstrated to be effective to risk stratify
patients with known coronary artery disease and guide for referral catheter-
ization.1-3 The American College of Cardiology/American Heart Association guide-
lines for exercise testing do not take a position regarding the utility of routine stress
testing after coronary artery bypass grafting (CABG).4 Risk stratification in this
substantial coronary artery disease population may have clinical significance because
repeating revascularization procedures reduces events at follow-up in high-risk
patients.5 SPECT studies might be useful not only to guide in the therapeutic decision
but also to determine the timing to retest patients during follow-up.6 Previous obser-
vation suggests that symptomatic and asymptomatic patients more than 5 years after
CABG may benefit from testing.2 The aim of this study was to assess the predictors
and the temporal characteristics of cardiac risk in patients undergoing stress SPECT
imaging 5 years after CABG.iovascular Surgery c July 2008
Acampa et al Surgery for Acquired Cardiovascular Disease
A
CDAbbreviations and Acronyms
CABG 5 coronary artery bypass grafting
CI 5 confidence intervals
SPECT 5 single-photon emission computed tomography
Patients and Methods
Patient Population
We studied 390 consecutive patients referred for stress cardiac
SPECT imaging after CABG. For the purpose of the present
investigation, we selected patients referred for SPECT imaging
5 years after CABG (range 60–66 months). Patients (n 5 20)
who underwent early (,60 days after SPECT) revascularization
procedures (percutaneous coronary intervention or repeated
CABG) were excluded. Although after CABG symptomatic
patients are usually referred for exercise testing, including radio-
nuclide imaging, there is no consensus for the evaluation of symp-
tom-free patients. Therefore, for asymptomatic patients, referral
for exercise perfusion imaging was at the discretion of individual
cardiologists. Eight patients were lost to follow-up. Thus, the final
population comprised 362 patients. All patients had off-pump
CABG. Of these patients, 258 (71%) underwent physical exercise
and 104 (29%), dipyridamole SPECT imaging. At the time of
SPECT, 267 patients were asymptomatic and 95 had angina symp-
toms. The prevalence of diabetes mellitus was 30% (31% in
asymptomatic and 27% in symptomatic patients; P 5 .52). The
ethics committee of our institution approved the protocol and all
patients provided written informed consent.
Study Protocol
Beta-blocking medications and calcium antagonists were withheld
for 48 hours and long-acting nitrates for 12 hours before testing.
For patients undergoing exercise test, symptom-limited treadmill
standardized protocols were performed, with monitoring of heart
rate and rhythm, blood pressure, and electrocardiography. Test
end points were physical exhaustion, horizontal or downsloping
ST-segment depression greater than 2 mm, ST-segment elevation
greater than 1 mm, moderate-to-severe angina, systolic blood pres-
sure decrease greater than 20 mm Hg, blood pressure greater than
230/120 mm Hg, dizziness, or clinically important cardiac arrhyth-
mia. For dipyridamole stress test, patients were instructed not to
consume products containing caffeine for 24 hours before the test.
Dipyridamole was infused at a dose of 0.56 mg $ kg21 $ min21 in-
travenous over 4 minutes. A dose of 100 mg of aminophylline was
administered intravenously in the event of chest pain or other symp-
toms or after significant ST depression. At peak exercise, or 4 min-
utes after completion of dipyridamole infusion, a bolus of 370 MBq
of technetium-99m sestamibi was intravenously injected. Patients
continued the exercise for an additional 60 seconds after tracer injec-
tion. For both types of stress, heart rate, blood pressure, and 12-lead
electrocardiographic data were recorded at rest, at the end of each
stress stage, at peak stress, and in the delay phases at rest. Maximal
degree of ST-segment change at 80 ms after the J-point of the elec-
trocardiogram was measured and assessed as horizontal, downslop-
ing, or upsloping. Four hours after the conclusion of the stress test,
1110 MBq of technetium-99m sestamibi was injected at rest.7The Journal of ThSPECT was performed 60 minutes after tracer injection for both
stress and rest studies.
SPECT Imaging
Gated SPECT acquisitions were performed with a dual-head rotat-
ing gamma camera (E.CAM, Siemens Medical Systems, Hoffman
Estates, Ill) equipped with a low-energy, high-resolution collimator
and connected with a dedicated computer system. No attenuation or
scatter correction was used. After filtered back-projection, short-
axis, vertical, and horizontal long-axis tomograms were generated.
A quantitative analysis of relative perfusion distribution in 17 myo-
cardial segments was performed.3 Each segment was scored on
a 5-point scoring system (0 5 normal, 1 5 mild, 2 5 moderate,
35 severe reduction, and 45 apparent absence of detectable tracer
uptake). A commercially available software program (Cedars-Sinai
Medical Center, Los Angeles, Calif) was used to automatically cal-
culate left ventricular ejection fraction and the variables incorporat-
ing both the extent and severity of perfusion defects: summed stress
score, summed rest score, and summed difference score.2,3 Stress
SPECT was considered abnormal with summed stress score of 3
or greater. Patients with abnormal SPECT were considered to
have no ischemia with a summed difference score less than 2,
mild-to-moderate ischemia with a summed difference score of 2 to
6, and severe ischemia with a summed difference score of 7 or
more.8
Follow-up
Data were obtained by scripted telephone interviews by a researcher
blinded to the patient’s test results. Cardiac events were defined as
cardiac death and nonfatal myocardial infarction. Patients who un-
derwent late revascularization (n 5 32) were censored at the time
of the procedures. Cardiac death was confirmed by review of death
certificate, hospital chart, or physician’s records. Cardiac enzyme
and electrocardiographic changes documented nonfatal myocardial
infarction. All patients were followed up for at least 1 year for the
outcome end points, and the median follow-up time was 27 months
(range interquartile 18–34 months).
Statistical Analysis
Continuous variables were expressed as a mean 6 standard devia-
tion and categorical data as percentage. Differences between groups
were assessed by unpaired t test and by c2 test with Yates correction,
as appropriate. The end point was the time from the index nuclear
testing to cardiac event, whichever occurred first. Effect of variables
on event-free survival was evaluated by stepwise multivariable Cox
proportional hazards model and hazards ratio, and 95% confidence
intervals (CI) were calculated9,10 (SPSS Inc, Advanced Models
13.0, Chicago, Ill). The variables considered were age, gender, hy-
pertension, smoking, hypercholesterolemia, diabetes, symptoms,
number of diseased vessels, and gated SPECT results. The entry
probability in the model was set at .05 and the P value used as the
cutoff for retention in the model was ,.1. The proportional hazard
assumption of the Cox model was checked separately for each cova-
riate before the regression analysis was performed. Such checking
was done by a graphical and analytical method. The graphs of
loge [2loge Sˆ (t)] versus loge(t) for each dichotomous covariate
were obtained to check that the curves were roughly parallel. Addi-
tionally, for each covariate a time-dependent covariate (covariate3 t)
was obtained and checked whether the coefficient of the latteroracic and Cardiovascular Surgery c Volume 136, Number 1 47
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was not rejected for any one of the covariates included in the Cox
model, except for stress type, which was treated as stratification vari-
able. Survival curves were constructed by the Kaplan–Meier method
to account for censored survival times and were compared with the
log–rank test (SPSS Inc, Advanced Models 13.0, Chicago, Ill). A
parametric survival model was used to identify which variables influ-
enced time to event and to estimate risk-adjusted event rates at 6-
month intervals during the follow-up and the length of time to specific
risk thresholds (JMP by SAS Institute, Inc, Cary, NC). For these pur-
poses, the estimated probability of failure, defined as 1 2 estimated
event-free survival probability,was calculated.On thebasis of the dis-
tribution of survival times in our cohort, a Weibull distribution was
selected for parametric survival and a goodfitwas foundwith STATA
version 9 for Windows (StataCorp LP, College Station, Tex).11,12
Results
SPECT Results and Outcome Events
Stress SPECT imaging was normal in 156 (43%) patients and
abnormal in 206 (57%). Of these latter patients, 144 (70%)
had evidence of ischemia and 62 (30%) did not. Ischemic
patients had a higher prevalence of male gender (96% vs
89%; P 5 .020), previous myocardial infarction (75% vs
49%; P , .001), and hypertension (49% vs 35%; P 5
.012) than did patients without ischemia. Angina symptoms
were present in 36% of patients with ischemia and in 20%
of those without (P , .001) and nitrate treatment was more
frequent in ischemic patients (P 5 .044). In the 144 patients
with ischemia, the mean summed difference score was
5.1 6 2. Among the 108 ischemic patients with previous
myocardial infarction, ischemia was infarct-related in 36
and non infarct-related in 40, whereas 32 patients had both
infarct- and noninfarct-related ischemia.
During the follow-up, 22 cardiac events occurred (6.1%
cumulative event rate). The events were cardiac death in 10
patients and nonfatal myocardial infarction in 12 patients.
Characteristics of patients with and without cardiac events
are reported in Table 1. A higher prevalence of diabetes
was observed in patients with events. SPECT results in
patients with and without events are reported in Table 2.
Patients with events showed a higher incidence of abnormal
SPECT and a higher summed difference score than did pa-
tients without events. In particular, among the 18 patients
with events and abnormal SPECT imaging, 14 had myocar-
dial ischemia.
A separate analysis was performed in asymptomatic pa-
tients with and without diabetes. The prevalence of ischemia
was comparable in patients with and without diabetes (30%
vs 36%; P 5 .27). Cardiac events occurred in 2 ischemic
patients with and in 4 ischemic patients without diabetes
(P 5 .73).
At multivariable Cox analysis, evidence of ischemia at
SPECT (c2 9.9, hazards ratio 3.7, 95% CI 1.5–9.1; P 5
.004) and diabetes (c2 9.6, hazards ratio 3.6, 95% CI 1.5–
8.5; P 5 .006) resulted in independent predictors of events,48 The Journal of Thoracic and Cardiovascular Surgery c Julywhereas the extent and severity of ischemia did not. The
event-free survival curves of patients according to SPECT
results are showed in Figure 1. At the end of the follow-up,
cumulative probability of event-free survival was 96% in pa-
tients with normal SPECT, 86% in those with abnormal
SPECT without ischemia, and 70% in those with ischemia
(log–rank test 10.6; P for trend 5 .008).
Change in Risk with Time
The parametric model for prediction of time to events identi-
fied SPECT results and diabetes as significant variables (c2
14.4 and 10.6, respectively; both P , .001). The survival
TABLE 1. Characteristics of patients with and without
cardiac events
Events
(n 5 22)
No events
(n 5 340) P value
Age (y) 61 6 8 63 6 8 .4
Male gender 91 90 .1
Prior myocardial
infarction
54 59 .6
Grafts (n) 2.5 6 0.4 2.3 6 0.6 .1
Arterial grafts (n) 1.6 6 0.3 1.5 6 0.4 .2
Incomplete
revascularization
9 13 .5
Hypertension* 36 41 .7
Smoking 9 10 .9
Hypercholesterolemiay 36 42 .6
Diabetes 54 29 .01
Symptoms 9 29 .06
Three-vessel disease 54 61 .6
Medications
Beta-blockers 36 32 .6
Nitroglycerin 36 35 .9
Calcium channel
blocker
45 41 .6
Categorical variables are presented as column percentages and continuous
variables as mean6 standard deviation. *Defined as blood pressure$140/
90 mm Hg or chronic antihypertensive treatment. yDefined by history or
recent cholesterol level $90th percentile for age and sex.
TABLE 2. SPECT results in patients with and without
cardiac events
Events
(n 5 22)
No events
(n 5 340) P value
Left ventricular
ejection fraction (%)
43 6 11 46 6 14 .3
Abnormal SPECT 82 55 .01
Summed stress score 8.1 6 5 7.5 6 8 .6
Summed rest score 4.5 6 5 5.2 6 6 .4
Summed difference score 3.4 6 3 2.0 6 2 .03
Categorical variables are presented as column percentages and continuous
variables as mean 6 standard deviation.2008
Acampa et al Surgery for Acquired Cardiovascular Disease
A
CDmodel including both variables (c2 21.4; P, .0001) revealed
that for both nondiabetic and diabetic patients, the cardiac
risk was greater for all time intervals and accelerated more
over time in patients with ischemia at SPECT than in those
without (Figure 2). Finally, the time to reach a defined risk
level (.5%) in patients with or without diabetes according
to SPECT results is depicted in Figure 3. Noteworthy,
patients without diabetes and with normal SPECT remained
below 5% estimated risk for the entire follow-up period.
Discussion
The results of the present study show that, in post-CABG pa-
tients, myocardial ischemia by SPECT imaging and the pres-
ence of diabetes independently influence the patient’s
outcome as well as the temporal characteristic of the patient’s
risk at long-term follow-up.
Risk assessment by nuclear cardiology is important for pa-
tient management and to guide therapeutic decision-making
in subjects with suspected or known coronary artery dis-
ease.13 Patients with previous CABG represent a substantial
coronary artery disease population.14 Risk stratification for
subsequent major cardiac events in these patients has clinical
importance, because repeated CABG could reduce the risk of
death in high-risk patients. It has been recently shown that pa-
tients with ischemic cardiomyopathy, undergoing repeated
CABG according to scintigraphic results, benefit from revas-
cularization as regards midterm outcome.5 Even though re-
peated CABG is still associated with increased cardiac risk
compared with first CABG, this risk seems to be related to pa-
tient selection.15,16 In particular, a high risk of repeated
CABG has been observed in patients with left ventricular
dysfunction.15,17 The results of the present investigation con-
firm that, after CABG, stress SPECT imaging results provide
Figure 1. Event-free survival curves by Kaplan–Meier analysis ac-
cording to SPECT imaging results. Stress SPECTstudies were con-
sidered normal with summed scores less than 3 and abnormal
with summed scores of 3 or more. In abnormal studies, myocardial
ischemia was defined by the presence of a summed difference
score of 2 or more.The Journal of Thprognostic information useful to identify patients at high risk
of major cardiac events. Similarly, previous studies showed
the prognostic value of SPECT imaging in the evaluation
of post-CABG patients.2,13,18 In particular, it has been dem-
onstrated that myocardial perfusion defects by SPECT imag-
ing, performed 7 years after CABG, were independent
predictors of subsequent cardiac death or myocardial infarc-
tion.18 It has also been reported that nuclear variables, such as
infarct size and myocardial ischemia, were predictors of
cardiac death in patients more than 5 years after CABG.2
In agreement with these previous studies, our findings show
Figure 2. Estimated probability of failure by 6-month intervals in
patients without (A) or with diabetes (B) according to SPECT
imaging results (circles 5 normal, squares 5 abnormal without
ischemia, and triangles 5 abnormal with ischemia).
Figure 3. Estimated time from index test to reach the selected risk
level (5%) of cardiac events, in patients with or without diabetes
according to SPECT imaging results.oracic and Cardiovascular Surgery c Volume 136, Number 1 49
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imaging in such patients. Moreover, even though diabetes
was a predictor of unfavorable outcome, the presence of
myocardial ischemia at SPECT had the greatest prognostic
power. In our patient population, the infarct size did not prove
to be a univariate predictor of major cardiac events. However,
the combination of infarct size with the presence of myocar-
dial ischemia determined a decrease in patient survival, more
evident after the third year of follow-up (as shown in
Figure 1).
In patients with coronary artery disease, cardiac risk is
considered to be high with an annual event rate greater
than 5%.2,19 The time to reach a significant risk is clinically
important in post-CABG patients, considering that the risk
of a hard event increases with time in the overall population
with known coronary artery disease and normal SPECT
results.6 Accordingly, from our data it emerged that in post-
CABG patients a normal stress SPECT is reassuring in
the subgroup of subjects without diabetes (Figure 2). On the
other hand, in the subgroup of patients with diabetes, the
probability of failure seems to be less reassuring. In fact,
the risk of a hard event increases with time and is accelerated
as compared with patients without diabetes, also in the pres-
ence of a normal SPECT. Thus, diabetes is an important de-
terminant in cardiac risk and in its evolution, in both patients
with normal and abnormal SPECT results. These findings are
consistent with those of a previous investigation.6 In inter-
preting our results, it should be considered that diabetes is as-
sociated with lipid, platelet, and coagulation abnormalities,
contributing to accelerated atherogenesis and thrombogene-
sis and diffuseness of coronary atherosclerosis.20-22 More-
over, endothelial dysfunction, platelet and coagulation
abnormalities, andmetabolic disorders associated with diabe-
tes may also contribute to the complex and difficult healing
process after arterial wall injury.23
Considering the acceleration in the cardiac risk in diabetic
patients with abnormal SPECT and myocardial ischemia
after 12 months (Figures 2 and 3) from the imaging study,
a clinical weighed decision should be considered in these
subgroups of patients as regards referral for invasive proce-
dures. Differently, the time to reach a risk level characterized
by an annual event rate greater than 5% in the nondiabetic
population with abnormal SPECT without ischemia is
relaxed, and it needs more than 3 years before to require
a control study during the follow-up (Figure 3).
Limitations
In this study, the event rate was relatively low, as expected in
such a low-risk population (ie, revascularized patients with
relatively preserved left ventricular function). Despite the
limited power to detect the level of some differences between
patients with and without events, the prognostic power of
SPECT imaging and diabetes is demonstrated. Finally,
follow-up angiography was not performed in this study;50 The Journal of Thoracic and Cardiovascular Surgery c Julythus, the accuracy of SPECT in distinguishing graft stenosis
from disease progression in untreated vessels cannot be
investigated.
Conclusions
Stress cardiac tomography performed 5 years after CABG is
useful to stratify patients at risk of cardiac events. Parametric
survival model estimates time to predefined risk and the level
of risk at specific time intervals after CABG.
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